Back

Long-term efficacy of tailored prolonged immunosuppressive therapy in biopsy-proven virus- negative myocarditis: a single center propensity weighted study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: The role of genetics and immunology in myocarditis Myocarditis ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Giordani

University of Padua, Padova (Italy)

6 More presentations in this session

Presentation thumbnail
Genetic testing in inflammatory cardiomyopathy/myocarditis: a red flag for cardiomyopathy-like histologic findings
Professor K. Pilichou (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Myocardial injury causes changes in the transcriptional and regulatory landscape of adaptive immune cells in the heart
Ms N. De Winter (London, GB)
Abstract Slides Video
Presentation thumbnail
Modulation of myocardial inflammation, fibrosis development and ventricular arrhythmogenicity by endurance exercise in murine coxsackievirus B3 myocarditis
Doctor K. Favere (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
Association between anti-cardiac autoantibodies in acute myocarditis and downstream clinical outcomes
Doctor A. Iacob (London, GB)
Abstract Slides Video
Presentation thumbnail
Immunomodulation to target biopsy-proven myocardial inflammation in genetic cardiomyopathies: a pilot report
Doctor G. Peretto (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
The role of genetics and immunology in myocarditis

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Independent predictors of dismal and favourable outcome in adult and paediatric myocarditis: data from the multicentric Italian Rare Biopsy-proven Myocarditis Registry
thumbnail
Congress Presentation
Acute myocarditis, a hidden disease: trying to describe diagnostic workflows and to predict mid term outcomes
thumbnail
Congress Presentation
Efficacy and safety of monoclonal antibodies targeting interleukin-5 and interleukin-4/13 pathways in eosinophilic myocarditis: a single-center experience.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources